APA

Glaysher M. A., Mohanaruban A., Prechtl C. G., Goldstone A. P., Miras A. D., Lord J., Chhina N., Falaschetti E., Johnson N. A., Al-Najim W., Smith C., Li J. V., Patel M., Ahmed A. R., Moore M., Poulter N., Bloom S., Darzi A., Le Roux C., Byrne J. P. & Teare J. P. (20180716). A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus. : BMJ open.

Chicago

Glaysher Michael Alan, Mohanaruban Aruchuna, Prechtl Christina Gabriele, Goldstone Anthony P, Miras Alexander Dimitri, Lord Joanne, Chhina Navpreet, Falaschetti Emanuela, Johnson Nicholas Andrew, Al-Najim Werd, Smith Claire, Li Jia V, Patel Mayank, Ahmed Ahmed R, Moore Michael, Poulter Neil, Bloom Stephen, Darzi Ara, Le Roux Carel, Byrne James P and Teare Julian P. 20180716. A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus. : BMJ open.

Harvard

Glaysher M. A., Mohanaruban A., Prechtl C. G., Goldstone A. P., Miras A. D., Lord J., Chhina N., Falaschetti E., Johnson N. A., Al-Najim W., Smith C., Li J. V., Patel M., Ahmed A. R., Moore M., Poulter N., Bloom S., Darzi A., Le Roux C., Byrne J. P. and Teare J. P. (20180716). A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus. : BMJ open.

MLA

Glaysher Michael Alan, Mohanaruban Aruchuna, Prechtl Christina Gabriele, Goldstone Anthony P, Miras Alexander Dimitri, Lord Joanne, Chhina Navpreet, Falaschetti Emanuela, Johnson Nicholas Andrew, Al-Najim Werd, Smith Claire, Li Jia V, Patel Mayank, Ahmed Ahmed R, Moore Michael, Poulter Neil, Bloom Stephen, Darzi Ara, Le Roux Carel, Byrne James P and Teare Julian P. A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus. : BMJ open. 20180716.